October 6, 2017 6:50pm

Algorithms and ETF exposure are amplifying the downside and smothering sentiment

While option expiration and rebalancing are ahead on the 20th

 

Pre-open indications: 6 hit and 2 miss (by pennies)

Out and about: Biostage (BSTG) a “Three Card Monty” company crashes to $0.10 down -52.40% – a tale of egos, ineptitude, mismanagement and a BOD that self-serviced … as usual shareholders are the victims, after $30 M was spent for a “nothing” as their investor deserts the company!

 

The interpretation of the truth of “our” universe is reported - here!

 

I answer one question, in which company should investors commit and keep their money. In the grip of rotating cycles and disparaging trends, what is the price of sector knowledge – a subscription!  


 

Friday’s results have implications to Monday’s sector activity as a daily report may say little or a lot and it serves as insurance that all indications are being examined and evaluated!

 

Henry’omics:

From the pre-open’s newsletter “the butterfly effect … Is a concept that states "small causes can have larger effects". Forget, volume, volatility, momentum and relative strength etc. – it’s the credibility of management teams and the reliability of the development platform.”

Threats, dangers and risks stem from a wide variety of sources, including management teams and markets as well as financial uncertainties, continued liabilities (as to their perception in the universe) and their capacity to understand strategic versus tactical execution. Had the butterfly not flapped its wings, the trajectory of the share price might have been vastly different <sarcasm>.

 

The advance/decline line scenario of 43 SCGT & RT covered companies:   

·         The open was negative with an A/DL of 19/21 and 3 flats;

·         10:30 am was negative with an A/DL of 11/29 and 3 flats;

·         The mid-day was negative with an ADL of 10/30 and 3 flats;

·         The close was negative with an A/DL of 15/28 and 3 flats;

 

Pre-open indications: 6 hit and 2 miss

·         Athersys (ATHX) closed down -$0.03 – hit;

·         Applied Genetic Technologies (AGTC) closed up +$0.00 – hit;

·         BioLife Solutions (BLFS) closed down -$0.01 – hit;

·         Biostage (BSTG) closed down -$0.1189 – hit;

·         Mesoblast (MESO) closed down -$0.30 – hit;

·         Cesca Therapeutics (KOOL) closed up +$0.10 – miss;

·         uniQure NV (QURE) closed up +$0.09 – miss;

·         Vericel (VCEL) closed down -$0.40 – hit;

 

Out and about:

Biostage (BSTG) Breech, breech … breech

 http://www.regmedinvestors.com/articles/9933

BSTG has been delisted from NASDAQ effective 10/6/17 to trade on the OTCQB, Pecos investment is in the wind and that ain’t all, what a MESS! Another nail in its cross of demise as CMO and President resigns while the company seeks any alternative... 

 

 

Some of MY working trend lines or indications:

The greatest volume to the downside:  BSTG, MDXG, SGMO, VCEL and JUNO

Upside volume was weighted to:  CYTX, IMUC, CAPR, BLUE and RGNX

Biggest $ downside: XON (-$1.17), JUNO (-$1.11), SGMO (-$0.70), VCEL (-$0.40) and ADRO (-$0.40)

Largest $ upside:  BLUE (+$1.75), RGNX (+$0.50), STML (+$0.15), CYTX (+$0.14) and CLBS (+$0.11)

Flat:  KITE at $79.79, AGTC at $4.00 and AXGN at $18.65

 

 

Counting the week’s apples:

CAPR closed up +$0.05 after being down -$0.31 after Wednesday’s  -$0.16 after Tuesday’s +$0.01 after Monday’s  +$0.42– CAPR can’t keep fooling investors for long with their brand of hype…I still think the HYPE is overplayed …

VCEL was down again -$0.40 after being down -$0.68 after Wednesday’s +$0.025 after Tuesday’s +$0.05 post Monday’s -$0.15 – an Icarus flight and should have financed in an overnight … short sighted management

As HSGX closed up again +$0.06 after being up +$0.08 post Wednesday’s +$0.02 after Tuesday’s +$0.05 after Monday’s flat at $1.98 – a good week ending at $2.19 …

While AXGN was flat at $18.65 after being up +$0.05 after closing flat at $18.60 after Tuesday’s -$0.50 following Monday’s -$0.25 while MDXG was down -$0.40 post yesterday’s +$0.05 post Wednesday’s +$0.72 after Tuesday’s down -$1.03 after Monday’s +$0.91 … the merry-go-round turns and burns;

AGTC was flat at $4.00 after being down -$0.10 post Wednesday’s -$0.05 after Tuesday’s +$0.05 post Monday’s +$0.15 … as I stated the upside won’t last? I haven’t seen or heard of ANY officer buys … AGTC can’t escape the downside trap …

AST was down again -$0.05 after yesterday’s  -$0.08 after being flat at $3.45 post being down -$0.15 after Monday’s +$0.20 while mothership BTX was up +$0.01 after being  down -$0.03 post yesterday’s -$0.02 after Tuesday’s +$0.05 after Monday’s -$0.05 … they both NEED cash to prop their balance sheets

Cellectis S.A. (CLLS) dumped  again another -$0.28 after being down -$0.25 after yesterday’s jumped +$0.48 after falling -$0.34 post Monday’s pop of +$0.53, as I had stated … watch the merry-go-round but, don’t wait for the music to stop;

Immuno-oncologists - JUNO was down again another -$1.11 after being down  -$0.19 post Wednesday’s  -$0.19 after Tuesday’s -$0.64 after Monday’s +$0.88; KITE was flat again at $179.79 while BLCM was down -$0.07 after being down up +0.04 post Wednesday’s +$0.11 after being down -$0.52 post Monday’s +$0.26 as VSTM slipped -$0.14 more after -$0.04 post Wednesday’s  -$0.03 after being +$0.07 after Monday’s +$0.08;

ATHX was down -$0.03 after being up +$0.31 after being down another -$0.04 post  -$0.01 after Monday’s  +$0.13 as many question their cash position going forward and their clinical “manufacturing” issues as trials continue …

RGNX was up again +$0.50 after Thursday’s +$1.15 after being flat at $32.00 post being down -$1.50 but, is opting to back away from a deal to buy Dimension Therapeutics Inc. (DMTX). RGNX had announced plans to buy Dimension in an all-stock transaction.  Any time one has a doubt – wait, RGNX usually rebounds … by walking they receive $2.85 M … I keep telling you!

SGMO got slashed again -$0.70 after being down -$0.35 after Wednesday’s +$0.25 post Tuesday’s +$0.55 after Monday’s +$1.20 while ONCE was down again -$0.04 after Wednesday’s -$0.66 post yesterday’s -$1.19 after Monday’s +$0.21 as BLUE jumped +$1.75 after diving -$3.40 after jumping +$1.85 after Tuesday’s +$2.10 after Monday’s dropping of -$11.90 …

FATE was down -$0.08 after being up +$0.03 post being down -$0.05 post Tuesday’s +$0.05 after Monday’s +$0.21;

MESO dumped -$0.30 after jumping +$0.43 after Wednesday’s +$0.25 after dropping Tuesday’s -$0.03 following Monday’s +$0.32

CYTX was up again +$0.14 after being up +$0.10 post Wednesday’s +$0.02 post being +$0.01 after Monday’s flat at $0.358 – still looking at “strategic options” while another criminal, OSIR was down -$0.06 after being up again +$0.01 after +$0.03 after being up +$0.06 after being down -$0.06

PSTI was down -$0.01 after being flat at $1.50 after being up +$0.03 following being on the losing side of the trade -$0.06, when will they ever learn – it has to be considered trustworthy by shareholders

 

 

Daily analytics:

All three benchmarks posted solid weekly gains. The Dow industrials rose 1.7% while the S&P 500 was up 1.2%. Both have risen for four straight weeks. The NASDAQ rose 1.5% in its second straight weekly gain.

  • The Dow declined less than 2 points to 22,773.67, just barely ending a seven-day win streak.
  • The S&P 500 fell 2.74 points, or 0.1%, to finish at 2,549.33, putting an end to an eight-day streak that has taken it to repeated records.
  • The NASDAQ switched between small gains and losses throughout the session but ended slightly higher, eking out a record close after rising 4.82 points, or 0.1%, to 6,590.18.

 

The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market; Friday traded 9.65, up +5.01% …

  • Thursday traded at 9.19, down -4.57% after Wednesday traded at 9.63, up +1.26% after Tuesday traded at 9.57, up +1.27 after Monday traded at 9.45, down -0.63% … after last Friday traded at 9.51, down -0.42%

 

Welcome to another day of the sector’s roller coaster …

… The iShares Russell 2000 (IWM) indicated:

·         Friday was down -0.11%

·         Thursday +0.27%

·         Wednesday -0.30%

·         Tuesday +0.21%

·         Monday +1.23

·         Last Friday +20%

 

… The Russell 2000 (RUT)

·         Friday lost -1.87 points or -0.12%

·         Thursday gained 4.32 points, or 0.3%

 

… The iShares NASDAQ Biotechnology (IBB) indicated:

·         Friday was down -0.11%

·         Thursday +0.11%

·         Wednesday +0.78%

·         Tuesday -0.23%

·         Monday +1.51%

·         Last Friday +0.92%

 

 

The count - decliners versus gainers:

……. look at the differences in the spreads as decliners jump and %

·         Friday’s decliners ranged from -0.05% <ONCE -$0.04> to -52.40% <BSTG -$0.119> in 28 equities;

·         Thursday’s decliners ranged from -0.05% <ONCE -$0.04> to -24.99% <BSTG -$0.08> in 21 equities;

·         Wednesday’s decliners ranged from -0.42% <JUNO -$0.19> to -8.32% <KOOL -$0.40> in 16 equities;

·         Tuesday’s decliners ranged from -0.45% <ONVO -$0.01> to -8.05% <MDXG -$1.03> in 23 equities;

·         Monday’s decliners ranged from -0.01% <KITE -$0.02> to -8.66% <BLUE -$11.90> in 14 equities;

·         Last Friday’s decliners ranged from -0.08% <ONCE -$0.07> to -5.15% <OSIR -$0.25> in 14 equities;

Versus

… Look at the percentage’s (%) and spreads …

·         Friday’s gainers ranged from +0.36% <BTX +$0.01> to +29.55% <CYTX +$0.14> in 12 equities;

·         Thursday’s gainers ranged from +0.22% <OSIR -$0.01> to +24.49% <CYTX +$0.10> in 20 equities;

·         Wednesday’s gainers ranged from +0.42% <VCEL +$0.025> to +6.38% <CYTX +$0.023> in 22 equities;

·         Tuesday’s gainers ranged from +0.31% <XON +$0.06> to +33.98% <KOOL +$1.22> in 18 equities;

·         Monday’s gainers ranged from +0.24% <ONCE +$0.21> to +13.86% <CAPR +$0.42> in 26 equities;

·         Last Friday’s gainers ranged from +0.04% <KITE +$0.08> to +35.87% <CAPR +$0.30> in 23 equities;

 

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.